General and Thoracic Surgery

Faculty Labs

The Bondoc Lab studies the molecular origins of pediatric hepatoblastoma, with a main focus on how developmental deviations and tumor cell heterogeneity drive disease initiation, progression, and therapeutic response.

The Galganski Lab’s goal is to develop new ways to treat disease before birth, including anomalies such as congenital diaphragmatic hernia, myelomeningocele and twin to twin transfusion syndrome.

The Helmrath Lab studies intestinal disease and regeneration, with a main focus on how intestinal stem cells drive intestinal adaptation and can be leveraged to develop regenerative therapies for gastrointestinal diseases.

The Lim Lab pioneers innovation in prenatal diagnosis and in utero therapy, integrating advanced risk stratification, biomarker discovery, translational operative models, and longitudinal multidisciplinary care to understand fetal disease, intervene before birth, and improve short‑ and long‑term outcomes.

The Shin Lab’s research focuses on deciphering the molecular and cellular mechanism of childhood liver cancer with a focus on fibrolamellar carcinoma and to investigate the role of facultative postnatal hepatic progenitor cells in liver disease.

The Timchenko Lab's goal is to elucidate molecular mechanisms of hepatocellular carcinoma and hepatoblastoma with the focus on hepatic stem cells and CSCs as the origin of both.